Kornitzer Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-765,500
Closed -$9.45M 487
2024
Q4
$9.45M Sell
765,500
-6,200
-0.8% -$71K 0.18% 155
2024
Q3
$8.78M Buy
771,700
+6,200
+0.8% +$62.2K 0.16% 187
2024
Q2
$5.47M Sell
765,500
-39,260
-5% -$300K 0.1% 240
2024
Q1
$5.39M Hold
804,760
0.1% 247
2023
Q4
$5.23M Hold
804,760
0.1% 247
2023
Q3
$7.6M Buy
804,760
+24,305
+3% +$293K 0.16% 206
2023
Q2
$10.9M Buy
780,455
+97,945
+14% +$1.67M 0.21% 147
2023
Q1
$12.8M Buy
682,510
+75,065
+12% +$1.23M 0.26% 120
2022
Q4
$8.36M Sell
607,445
-160,267
-21% -$2.45M 0.17% 186
2022
Q3
$14.7M Sell
767,712
-350
-0% -$6.38K 0.31% 90
2022
Q2
$11.7M Buy
768,062
+92,985
+14% +$1.38M 0.23% 146
2022
Q1
$13.8M Buy
675,077
+6,569
+1% +$134K 0.23% 155
2021
Q4
$19.5M Buy
668,508
+11,125
+2% +$318K 0.29% 117
2021
Q3
$14.2M Sell
657,383
-60,000
-8% -$1.45M 0.22% 182
2021
Q2
$18.4M Sell
717,383
-275,160
-28% -$5.88M 0.28% 143
2021
Q1
$18.1M Sell
992,543
-42,717
-4% -$710K 0.29% 127
2020
Q4
$11.9M Buy
+1,035,260
New +$9.46M 0.2% 173

Other funds holding CDMO

Kornitzer Capital Management's CDMO Position: Q1 2025 in Review

Kornitzer Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 765,500 shares — an estimated $9.45M sold.

Kornitzer Capital Management first reported a position in CDMO in Q4 2020 and held it in 17 quarters. The position peaked at $19.5M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Kornitzer Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Kornitzer Capital Management sold 765,500 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $9.45M.
  • Kornitzer Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
  • Kornitzer Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $19.5M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Kornitzer Capital Management's 13F filing for Q1 2025, filed 2 May 2025.